feed,title,long_url,short_url
Benzinga,Moderna's Omicron-Adapted Booster Maintains Response Through Three Months,https://benzinga.com/general/biotech/22/10/29325161/modernas-omicron-adapted-booster-maintains-response-through-three-months,https://bit.ly/3MHQ5fv
Benzinga,RedHill Biopharma Shares Surge New Treatment Patent For Its Late-Stage COVID-19 Candidate,https://benzinga.com/general/biotech/22/10/29324644/redhill-biopharma-shares-surge-new-treatment-patent-for-its-late-stage-covid-19-candidate,https://bit.ly/3gnEXrV
